Search Results - "M.E. Hellard"

Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia by Winter, R.J, Stoové, M, Degenhardt, L, Hellard, M.E, Spelman, T, Jenkinson, R, McCarthy, D.R, Kinner, S.A

“…Highlights • We calculated the incidence of non-fatal overdose among recently released prisoners. • Incidence was 27/100 person-years (PY) over 6 months…”
Get full text

Resumption of injecting drug use following release from prison in Australia by Winter, R.J, Young, J.T, Stoové, M, Agius, P.A, Hellard, M.E, Kinner, S.A

“…Highlights • 41% of 533 ex-prisoners with IDU history resumed IDU over 6 months after prison. • The highest incidence of IDU resumption occurred within 1 month…”
Get full text

P0841 : Successful community based treatment of hepatitis C in people who inject drugs by Wade, A.J, Macdonald, D, Doyle, J.S, Thompson, A.J, Roberts, S.K, Hellard, M.E

Get full text

Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study by Aspinall, E.J, Weir, A, Sacks-Davis, R, Spelman, T, Grebely, J, Higgs, P, Hutchinson, S.J, Hellard, M.E

“…Abstract Background People who inject drugs (PWID) are at risk of hepatitis C virus (HCV). It is plausible that PWID who receive a diagnosis of HCV will reduce…”
Get full text

Hepatic Fibrosis Measured by Elastography among People who Inject Drugs with Chronic HCV in Community Settings: The Tap Study by Doyle, J.S, Dietze, P, Desmond, P, Iser, D.M, Stoove, M, McBryde, E, Higgs, P, Hellard, M.E, Thompson, A.J

Get full text

Suitability of HCV treatment in primary care settings for individuals with HIV/hepatitis C coinfection by Doyle, J.S, Bowring, A.L, Iser, D.M, Sasadeusz, J, Roney, J, O’Reilly, M, Fairley, C, Gane, E, Hoy, J, Matthews, G.V, Medland, N, Moore, R, Prins, M, Stoové, M, Ban-Kiem, T, Hellard, M.E

Get full text

High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatment by Bowing, A.L, Doyle, J.S, Iser, D.M, Sasadeusz, J, Roney, J, O’Reilly, M, Fairley, C, Gane, E, Hoy, J, Matthews, G.V, Medland, N, Moore, R, Prins, M, Stoové, M, Ban-Kiem, T, Hellard, M.E

Get full text

Feasibiliy of Recruiting People who Inject Drugs into a Nurse-Led Model of Care Trial: The Tap Study by von Bibra, S, Doyle, J.S, Higgs, P, Dietze, P, Desmond, P, Stoove, M, McBryde, E, Burke, L, Lupi, J, Bryant, M, Thompson, A.J, Hellard, M.E

Get full text

Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study by Grebely, J, Dalgard, O, Conway, B, Cunningham, E, Bruggmann, P, Hajarizadeh, B, Amin, J, Marks, P, Quiene, S, Applegate, T.L, Swan, T, Byrne, J, Lacalamita, M, Dunlop, A.J, Bruneau, J, Hellard, M.E, Matthews, G.V, Powis, J, Shaw, D, Thurnheer, C.M, Weltman, M, Kronborg, I, Cooper, C, Feld, J.J, Fraser, C, Litwin, A, Dillon, J, Read, P, Gane, E, Dore, G.J

Get full text

P733 NEW HEPATITIS C INFECTION AND RE-INFECTION AMONG HIV CO-INFECTED MEN IN MELBOURNE, AUSTRALIA by El-Hayek, C, Doyle, J.S, Cuevas, M, Lim, M, Fairley, C.K, Leslie, D.E, Roth, N, Tee, B.K, Stoove, M, Hellard, M.E

Get full text

P734 A SYSTEMATIC REVIEW OF INTERVENTIONS TO REDUCE ALCOHOL CONSUMPTION AMONG INDIVIDUALS WITH CHRONIC HCV INFECTION by Doyle, J.S, Hunt, D, Aspinall, E.J, Hutchinson, S.J, Goldberg, D.J, Nguyen, T, Falck-Ytter, Y, Morgan, R.L, Smith, B, Stoove, M, Lutchers, S, Thompson, A.J, Wiktor, S.Z, Hellard, M.E

Get full text

Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia by Miller, E.R, Hellard, M.E, Bowden, S, Bharadwaj, M, Aitken, C.K

“…Summary Background and aims Current injecting drug users (IDU) in major street drug markets within greater Melbourne were recruited to a longitudinal study on…”
Get full text

P36 Outcomes of general practitioner prescription of direct acting antiviral therapy utilising a remote consultation referral pathway in Western Victoria by A.J. Wade, A. McCormack, C. Roder, K. McDonald, M. Wardrop, E. Athan, M.E. Hellard

Get full text

811 RESPONSE TO TREATMENT FOLLOWING RECENTLY ACQUIRED HEPATITIS C VIRUS INFECTION by Doyle, J.S, Deterding, K, Grebely, J, Wedemeyer, H, Sacks- Davis, R, Matthews, G, Rice, T, Morris, M, McGovern, B.H, Kim, A.Y, Bruneau, J, Lloyd, A.R, Page, K, Manns, M, Hellard, M.E, Dore, G.J

Get full text

O17 Eliminate Hepatitis C Partnership: clinical site scoping by E. Wong, A. Pedrana, B.L. Draper, J. Gold, J. Richmond, M. Stoove, J.S. Doyle, A.J. Thompson, M.E. Hellard

Get full text

O20 Opportunities and challenges experienced when treating HCV in people who inject drugs (PWID) through a nurse-led outreach model by K. Allardice, S. Von Bibra, J.S. Doyle, P.M. Dietze, P. Desmond, M. Stoove, E. McBryde, P. Higgs, A.J. Thompson, M.E. Hellard

Get full text

O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective by J.S. Doyle, A.L. Bowring, J. Cutts, J. Roney, D.M. Iser, J. Sasadeusz, M. O’Reilly, C. Fairley, E. Gane, J. Hoy, G.V. Matthews, N. Medland, R. Moore, M. Prins, M. Stoové, B.K. Tee, M.E. Hellard

Get full text

O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study by J. Grebely, O. Dalgard, B. Conway, E. Cunningham, P. Bruggmann, B. Hajarizadeh, J. Amin, P. Marks, S. Quiene, T.L. Applegate, T. Swan, J. Byrne, M. Lacalamita, A. Dunlop, J. Bruneau, M.E. Hellard, G.V. Matthews, J. Powis, D. Shaw, M.C. Thurnheer, M. Weltman, I. Kronborg, C. Cooper, J.J. Feld, C. Fraser, A. Litwin, J. Dillon, P. Read, E. Gane, G.J. Dore

Get full text

Failure to detect norovirus in a large group of asymptomatic individuals by Marshall, J.A, Hellard, M.E, Sinclair, M.I, Fairley, C.K, Cox, B.J, Catton, M.G, Kelly, H, Wright, P.J

“…Noroviruses are a major cause of both sporadic and epidemic gastroenteritis in humans, but the mechanisms by which norovirus circulates within the community…”
Get full text

Scale‐up of hepatitis C treatment in prisons is key to national elimination by Papaluca, Timothy, Hellard, Margaret E, Thompson, Alexander J V, Lloyd, Andrew R

Get full text